AbbVie Strengthens Immunology Leadership with $10.9 Billion Apogee Therapeutics Acquisition – Meet them this November

Talawar Therapeutics Heads to Nasdaq via SPAC Deal to Bankroll Eczema Asset

10 Clinical Trials to Watch Out for in the latter half of 2026 – Read here

Akero execs reunite to advance long-acting psoriasis pill

Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug

InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test

Sanofi halts development of troubled immune drug in eczema

Chasing Dupixent, a biotech aims to make better antibody drugs for eczema

Regeneron backs $75M series A for antibody upstart Infinimmune

Anuj Singhal

Chief Executive Officer Kalm therapeutics

Wednesday 4th November 2026

Advancing Delivery Systems to Improve Patient Experience & Enhance Therapeutic Impact

12:00 pm

Exploring innovative delivery systems, improving usability, to increase patient adherence
Enhancing drug delivery performance to maximize efficacy and improve outcomes
Differentiating therapies through formulation, strengthening positioning, to gain competitive advantage